Free Trial
ASX:PTX

Prescient Therapeutics (PTX) Stock Price, News & Analysis

Prescient Therapeutics logo

About Prescient Therapeutics Stock (ASX:PTX)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
537,831 shs
Average Volume
N/A
Market Capitalization
A$38.66 million
P/E Ratio
N/A
Dividend Yield
5.88%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Prescient Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

PTX Stock News Headlines

This Cold War “Accident” Could Unleash New $100 Trillion AI Boom
Obscure Metal More Valuable than Gold and Bitcoin… COMBINED? This strange "AI Metal" holds the key to the $100 trillion AI boom. Which is why Jeff Brown recently traveled to a location that has one of the highest concentrations of this metal in the world. And you won't believe what he uncovered.
See More Headlines

PTX Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Prescient Therapeutics investors own include NOVONIX (NVX), SkyCity Entertainment Group (SKC), KLA (KLAC), Findi (FND) and Chalice Mining (CHN).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ASX:PTX
CIK
N/A
Fax
N/A
Employees
171
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$8.24 million
Net Margins
-221.91%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
A$3.71 million
Price / Cash Flow
1.91
Book Value
A$0.02 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
A$38.66 million
Optionable
Not Optionable
Beta
1.19
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (ASX:PTX) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners